BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2290707)

  • 21. Interferon-alpha-induced apoptosis in human erythroid progenitors.
    Tarumi T; Sawada K; Sato N; Kobayashi S; Takano H; Yasukouchi T; Takashashi T; Sekiguchi S; Koike T
    Exp Hematol; 1995 Nov; 23(12):1310-8. PubMed ID: 7589287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
    Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin.
    Muta K; Krantz SB
    J Cell Physiol; 1993 Aug; 156(2):264-71. PubMed ID: 7688370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An endogenous signal triggering erythroid differentiation: identification as thyroid hormone.
    Dinnen RD; White SR; Elsayed S; Yeh YI; Ebisuzaki K
    Cell Growth Differ; 1994 Aug; 5(8):855-61. PubMed ID: 7986750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Raf-1 protein mediates insulin-like growth factor-induced proliferation of erythroid progenitor cells.
    Sanders MR; Lu H; Walker F; Sorba S; Dainiak N
    Stem Cells; 1998; 16(3):200-7. PubMed ID: 9617895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.
    Ge Y; Li ZH; Marshall MS; Broxmeyer HE; Lu L
    Blood Cells Mol Dis; 1998 Jun; 24(2):124-36; discussion 137. PubMed ID: 9628849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the erythropoietin and stem-cell-factor receptors.
    Wu H; Klingmüller U; Besmer P; Lodish HF
    Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.
    Vlaski M; Lafarge X; Chevaleyre J; Duchez P; Boiron JM; Ivanovic Z
    Exp Hematol; 2009 May; 37(5):573-84. PubMed ID: 19375648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures.
    Sanders M; Sorba S; Dainiak N
    Exp Hematol; 1993 Jan; 21(1):25-30. PubMed ID: 8417957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells.
    Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S
    Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
    Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
    Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog signaling and cell cycle control in differentiating erythroid progenitors.
    Detmer K; Thompson AJ; Garner RE; Walker AN; Gaffield W; Dannawi H
    Blood Cells Mol Dis; 2005; 34(1):60-70. PubMed ID: 15607701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro proliferation and differentiation of erythroid progenitors of cord blood.
    Sakatoku H; Inoue S
    Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin receptor mutations and Olympic glory.
    Longmore GD
    Nat Genet; 1993 Jun; 4(2):108-10. PubMed ID: 8348144
    [No Abstract]   [Full Text] [Related]  

  • 36. The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors.
    Fibach E; Rachmilewitz EA
    Stem Cells; 1993 May; 11 Suppl 1():36-41. PubMed ID: 8318917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
    Weich NS; Tullai J; Guido E; McMahon M; Jolliffe LK; Lopez AF; Vadas MA; Lowry PA; Quesenberry PJ; Rosen J
    Exp Hematol; 1993 May; 21(5):647-55. PubMed ID: 8513865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin.
    Koury MJ; Bondurant MC
    Transfusion; 1990 Oct; 30(8):673-4. PubMed ID: 2219251
    [No Abstract]   [Full Text] [Related]  

  • 40. RHEX in the mix of erythropoietin signaling molecules.
    Broxmeyer HE
    J Exp Med; 2014 Aug; 211(9):1704. PubMed ID: 25155719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.